Bone Marrow Failure

These are conditions where the bone marrow doesn't make enough healthy blood cells, or the cells it makes are abnormal. This can lead to problems like anemia (low red blood cells), low white blood cells, and easy bruising or bleeding.

Condition

What people with Bone Marrow Failure report

Every report comes from a Lived member, sent anonymously.

Have you had Stem Cell Transplant for Bone Marrow Failure?

NameHow it went

About Bone Marrow Failure

What It Is

Bone marrow failure means the bone marrow, the spongy tissue inside bones where blood is made, cannot produce enough blood cells. Blood-forming stem cells in the marrow normally make red blood cells that carry oxygen, white blood cells that fight infection and platelets that help blood clot. When those stem cells are damaged or too few, one, two or all three of these counts fall. The symptoms follow from which counts are low. Too few red cells cause tiredness, weakness, pale skin, dizziness and breathlessness with effort. Too few white cells make infections more frequent and more serious. Too few platelets cause easy bruising, nosebleeds, bleeding gums, heavy periods and tiny red or purple spots on the skin called petechiae. Bone marrow failure can come on quickly or slowly, and a mild form may cause few symptoms. Bone marrow failure is an umbrella term rather than one disease. Acquired forms develop during life. The best known is aplastic anemia, in which the immune system attacks the marrow's stem cells. Related acquired conditions include paroxysmal nocturnal hemoglobinuria (PNH), which destroys red blood cells, raises the risk of blood clots and often appears alongside aplastic anemia, and myelodysplastic syndromes (MDS), a group of marrow disorders that can turn into leukemia. Inherited bone marrow failure syndromes, such as Fanconi anemia, dyskeratosis congenita, Shwachman-Diamond syndrome and Diamond-Blackfan anemia, are caused by gene changes present from birth. All of these are rare, and telling them apart matters because their treatments differ.

Causes & Risk Factors

In acquired aplastic anemia, the immune system attacks the blood-forming stem cells, usually for reasons no one can identify. Recognized contributors include chemotherapy and radiation, certain medicines, toxic chemicals such as benzene, some viral infections such as hepatitis, and, rarely, pregnancy. Even when an exposure is suspected, it is often hard to prove it was the cause, and many people have no identifiable trigger. Inherited syndromes come from gene changes that can be passed down in families, although a person may be the first in their family to be diagnosed. They usually appear in childhood, sometimes with clues outside the blood, such as short stature, thumb or forearm differences, unusual skin coloring, abnormal nails, poor digestion from a pancreas that does not work properly, or early lung scarring. Milder forms are increasingly recognized in adults. Age changes which cause is most likely. In children and young adults, immune aplastic anemia and inherited syndromes predominate. In older adults, low blood counts more often come from MDS, in which marrow cells acquire genetic changes and stop producing normal blood cells.

How It's Diagnosed

Diagnosis usually begins with a complete blood count (CBC), which measures red cells (reported as hemoglobin), white cells and platelets. A reticulocyte count, which measures newly made red cells, shows whether the marrow is keeping up. A very low count points to a production problem rather than blood loss or red cells being destroyed. Low counts alone are not a diagnosis, so clinicians first look for causes that can be reversed: low vitamin B12, folate or copper, thyroid, kidney or liver problems, infections such as HIV or hepatitis, and medicines or toxins. If two or more counts are low, or one is severely and unexpectedly low, a bone marrow aspirate and biopsy follows. A needle removes a small sample of liquid marrow and bone, which shows whether the marrow is nearly empty of blood-forming cells and whether abnormal or cancerous cells are present. Further tests look for chromosome changes, PNH cells and gene changes, both those acquired in the marrow and those inherited. A chromosome breakage test for Fanconi anemia and a telomere length test for dyskeratosis congenita and related disorders are often done, especially in younger people or when family history or physical features suggest an inherited cause. Severity guides treatment. In severe aplastic anemia, the marrow holds less than a quarter of the usual number of cells and blood counts are very low, for example neutrophils (the main infection-fighting white cells) below 500 per microliter or platelets below 20,000 per microliter. Very severe disease means neutrophils below 200, and the risk of serious infection rises as that number falls.

Treatment Options

Treatment depends on the type of marrow failure, how severe it is, the person's age and whether a matched donor is available. Mild, stable low counts may need only regular blood tests. Supportive care runs through every stage. Red cell transfusions relieve the symptoms of anemia, and platelet transfusions lower the risk of bleeding, but neither repairs the marrow. Many red cell transfusions build up iron in the body, which the care team monitors. When white counts are very low, medicines to prevent infection and fast treatment of any infection are central to staying safe. For severe acquired aplastic anemia, the two main options are a stem cell transplant and immunosuppressive therapy. An allogeneic stem cell (bone marrow) transplant replaces the failing marrow with blood-forming cells from a donor whose tissue type, called HLA, matches. It can cure the disease and is usually preferred for younger people who have a matched brother or sister. Its trade-offs are serious: the donor's immune cells can react against the body, the new cells can be rejected, and infections are a major risk. Immunosuppressive therapy is the usual first treatment for people over about 40 or without a matched sibling. It combines horse antithymocyte globulin (ATG, sold as Atgam), a hospital infusion that calms the immune attack on the marrow, with cyclosporine, an immune-suppressing pill, and often eltrombopag (Promacta), a pill that stimulates blood-forming cells and requires regular liver blood tests. Treatment lasts at least a year, counts improve gradually rather than at once, and the disease can return. If it does not work, a transplant from an unrelated donor is considered. Inherited syndromes are treated differently. Immunosuppressive therapy generally does not help them, so a transplant is the main option when counts fall severely, using gentler preparatory chemotherapy and checking that a related donor does not carry the same gene change. Some syndromes have their own treatments, such as steroids for Diamond-Blackfan anemia and pancreatic enzymes for Shwachman-Diamond syndrome. PNH and MDS also have specific treatments of their own.

What to Expect

The course varies widely with the type and severity. Some people with mild acquired disease have stable counts that are simply watched with blood tests. Severe aplastic anemia without treatment is often fatal, usually from infection or bleeding. With a transplant or immunosuppressive therapy, more than 80 to 90 percent of people are alive five years later. The first months of treatment are often demanding. Clinic visits can be as frequent as two or three times a week, with transfusions, blood tests and attention to infection: frequent handwashing, staying away from people who are sick and a yearly flu shot. After immunosuppressive therapy, counts may recover partly or fully, and because relapse is possible, blood counts continue to be checked for years. Long-term follow-up also watches for later changes. Roughly 1 in 10 to 1 in 5 people with acquired aplastic anemia later develop MDS or acute myeloid leukemia (AML), a blood cancer, and some develop PNH. Inherited syndromes carry a higher and earlier risk of these blood cancers, and some raise the risk of other cancers or affect organs such as the lungs, so monitoring extends beyond blood counts. Because inherited forms run in families, genetic counseling can help relatives understand their own risk and whether testing makes sense for them.

When to Seek Help

See a clinician if you have ongoing unexplained tiredness, frequent infections or easy bruising, or if a blood test shows more than one low blood count. If you have bone marrow failure, call your care team right away, at any hour, for a fever of 101.0°F (38.3°C) or higher or other signs of infection, since infections can become life-threatening when white counts are low. Also call promptly if you look unusually pale, feel much more tired or short of breath than usual, or notice new bruising or petechiae. Bleeding that starts for no clear reason or is hard to stop needs care right away: contact your care team or go to the emergency room.

Questions to Ask Your Doctor

  1. 1.Is my bone marrow failure acquired or inherited, and which tests will settle that?
  2. 2.How severe is it, and which of my blood counts matter most to watch?
  3. 3.Am I a candidate for a stem cell transplant, and should my brothers or sisters be tested as possible donors?
  4. 4.What exactly should I do if I get a fever or start bleeding, and whom do I call after hours?
  5. 5.What long-term monitoring will I need for MDS, leukemia or other complications?

Last reviewed • Oct 2026

Educational content, not medical advice.